SMTL ID : 6e4f.1

Crystal structure of ARQ 531 in complex with the kinase domain of BTK

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.15 Å
Oligo State
monomer
Ligands
1 x HRA: 1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-D-erythro-hexitol(Non-covalent)
2 x IMD: IMIDAZOLE(Non-covalent)
2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Reiff, S.D. et al., The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation. Cancer Discov (2018)
Release Date
2018-09-05
Peptides
Tyrosine-protein kinase BTK: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Tyrosine-protein kinase BTK